Clinical research magnesium isoglycyrrhizinate in the treatment of chronic hepatitis B

Objective To observe the clinical efficacy of magnesium isoglycyrrhizinate in the treatment of chronic hepatitis B.Methods 60 patieats with chronic hepatitis B were randomly divided into treated group and control group.Treated group included 30 patients,were treated with 150 mg magnesium isoglycyrrhizinate added into 100 ml 5% glucose injection liquid.Control group included 30 patients,were treated with 150 mg diammonium glycyrrhizinate added into 100 ml 5% glucose injection liquid.Results The level of ALT、AST and TBIL dropped more rapidly than that in contrust group and there were significant difference in symptoms recover between treated group and control group(P0.05).Conclusion Magnesium isoglycyrrhizinate can better improve hepatitis sufferers' symptom and liver functions than diammonium glycyrrhizinate in the group of chronic hepatitis B.